Enoxaparin Effect on Pregnancy Outcomes in a Patient with Elevated Plasminogen Activator Inhibitor-1
Background. Plasminogen activator inhibitor-1 (PAI-1) inhibits tPA and creates a prothrombotic state. Gene polymorphisms of PAI-1 are associated with elevated levels and adverse pregnancy outcomes. Case. A 36-year-old gravida 6, para 1-1-3-1 with elevated prepregnancy PAI-1 levels, a history of earl...
Saved in:
Main Authors: | Kathleen Minor, Heidi Leftwich |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Obstetrics and Gynecology |
Online Access: | http://dx.doi.org/10.1155/2020/7860324 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Functional Stability of Plasminogen Activator Inhibitor-1
by: Songul Yasar Yildiz, et al.
Published: (2014-01-01) -
Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects
by: Sándor Somodi, et al.
Published: (2018-01-01) -
Plasminogen Activator Inhibitor-1 Regulates LPS Induced Inflammation in Rat Macrophages through Autophagy Activation
by: Zhong-Hui Wang, et al.
Published: (2014-01-01) -
Weight-based enoxaparin thromboprophylaxis in young trauma patients: analysis of the CLOTT-1 registry
by: Sarah Lombardo, et al.
Published: (2024-07-01) -
Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity
by: Katarina Lalić, et al.
Published: (2015-01-01)